Grant

Therapeutic Idea for the Treatment of ALS with RASRx1902

Sponsored by United States Army Medical Research Acquisition Activity

$893.6K Funding

2 People

External

Related Topics

als treatment, therapeutic, rasrx1902, neurodegenerative diseases, drug development

People

Kevin Gaffney
Co-Investigator (COI)
Pharmacology﹒Assistant Research Professor
Kathleen Rodgers
Principal Investigator (PI)
Pharmacology﹒Associate Director